Filed: 11/14/2023ACC: 0001104659-23-117779
📋 What this filing means
ACUTA CAPITAL PARTNERS, LLC filed this quarterly 13F‑HR report disclosing 43 equity positions with a total reported market value of $149.21M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
43
Positions
$149.21M
Total AUM (reported)
18.46M
Total Shares
Allocation by class
COM$121.39M81.4%
COM SHS$12.10M8.1%
COM NEW$9.83M6.6%
SHS$3.54M2.4%
SPONSORED ADS$2.34M1.6%
*W EXP 07/07/2027$9.1K0.0%
Portfolio Concentration
Top 3$30.86M20.7%
4–10$51.72M34.7%
11–25$54.48M36.5%
Rest$12.16M8.1%
Top 3 weight
20.7%
Top 10 weight
55.3%
Voting Authority Distribution
Total shares with voting rights: 18.46M
Sole
Full voting authority
18.46M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole43
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings43
Rows:
TAYSHA GENE THERAPIES INC
SOLEShares3.83M
TypeSH
Market value$12.10M
8.11%
Sole
3.83M
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares16.05K
TypeSH
Market value$9.46M
6.34%
Sole
16.05K
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares244.48K
TypeSH
Market value$9.30M
6.23%
Sole
244.48K
Shared
0.00
None
0.00
AADI BIOSCIENCES INC
SOLEShares1.85M
TypeSH
Market value$8.95M
6.00%
Sole
1.85M
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares4.49M
TypeSH
Market value$7.67M
5.14%
Sole
4.49M
Shared
0.00
None
0.00
RAYZEBIO INC
SOLEShares344.57K
TypeSH
Market value$7.65M
5.13%
Sole
344.57K
Shared
0.00
None
0.00
ROCKET PHARMACEUTICALS INC
SOLEShares362K
TypeSH
Market value$7.42M
4.97%
Sole
362K
Shared
0.00
None
0.00
VENTYX BIOSCIENCES INC
SOLEShares205.38K
TypeSH
Market value$7.13M
4.78%
Sole
205.38K
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares138.20K
TypeSH
Market value$6.49M
4.35%
Sole
138.20K
Shared
0.00
None
0.00
KURA ONCOLOGY INC.
SOLEShares702.09K
TypeSH
Market value$6.40M
4.29%
Sole
702.09K
Shared
0.00
None
0.00
CYMABAY THERAPEUTICS INC
SOLEShares418K
TypeSH
Market value$6.23M
4.18%
Sole
418K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares121.02K
TypeSH
Market value$6.17M
4.13%
Sole
121.02K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares129K
TypeSH
Market value$4.95M
3.32%
Sole
129K
Shared
0.00
None
0.00
REPLIMUNE GROUP INC
SOLEShares151K
TypeSH
Market value$4.33M
2.90%
Sole
151K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares297.04K
TypeSH
Market value$4.31M
2.89%
Sole
297.04K
Shared
0.00
None
0.00
HILLEVAX INC
SOLEShares270.32K
TypeSH
Market value$3.64M
2.44%
Sole
270.32K
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares126.50K
TypeSH
Market value$3.54M
2.37%
Sole
126.50K
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares224.34K
TypeSH
Market value$3.44M
2.31%
Sole
224.34K
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC
SOLEShares122.34K
TypeSH
Market value$3.37M
2.26%
Sole
122.34K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS INC
SOLEShares94K
TypeSH
Market value$2.80M
1.87%
Sole
94K
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares555.26K
TypeSH
Market value$2.79M
1.87%
Sole
555.26K
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares300.13K
TypeSH
Market value$2.40M
1.61%
Sole
300.13K
Shared
0.00
None
0.00
IKENA ONCOLOGY INC
SOLEShares551.01K
TypeSH
Market value$2.39M
1.60%
Sole
551.01K
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares323.35K
TypeSH
Market value$2.09M
1.40%
Sole
323.35K
Shared
0.00
None
0.00
89BIO INC
SOLEShares33.80K
TypeSH
Market value$2.03M
1.36%
Sole
33.80K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
TAYSHA GENE THERAPIES INCSOLE | COM SHS | 3.83M | SH | $12.10M 8.11% | 3.83M | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 16.05K | SH | $9.46M 6.34% | 16.05K | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | COM | 244.48K | SH | $9.30M 6.23% | 244.48K | 0.00 | 0.00 |
AADI BIOSCIENCES INCSOLE | COM | 1.85M | SH | $8.95M 6.00% | 1.85M | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM | 4.49M | SH | $7.67M 5.14% | 4.49M | 0.00 | 0.00 |
RAYZEBIO INCSOLE | COM | 344.57K | SH | $7.65M 5.13% | 344.57K | 0.00 | 0.00 |
ROCKET PHARMACEUTICALS INCSOLE | COM | 362K | SH | $7.42M 4.97% | 362K | 0.00 | 0.00 |
VENTYX BIOSCIENCES INCSOLE | COM | 205.38K | SH | $7.13M 4.78% | 205.38K | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COM | 138.20K | SH | $6.49M 4.35% | 138.20K | 0.00 | 0.00 |
KURA ONCOLOGY INC.SOLE | COM | 702.09K | SH | $6.40M 4.29% | 702.09K | 0.00 | 0.00 |
CYMABAY THERAPEUTICS INCSOLE | COM | 418K | SH | $6.23M 4.18% | 418K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 121.02K | SH | $6.17M 4.13% | 121.02K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 129K | SH | $4.95M 3.32% | 129K | 0.00 | 0.00 |
REPLIMUNE GROUP INCSOLE | COM | 151K | SH | $4.33M 2.90% | 151K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 297.04K | SH | $4.31M 2.89% | 297.04K | 0.00 | 0.00 |
HILLEVAX INCSOLE | COM | 270.32K | SH | $3.64M 2.44% | 270.32K | 0.00 | 0.00 |
ALKERMES PLCSOLE | SHS | 126.50K | SH | $3.54M 2.37% | 126.50K | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 224.34K | SH | $3.44M 2.31% | 224.34K | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INCSOLE | COM NEW | 122.34K | SH | $3.37M 2.26% | 122.34K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INCSOLE | COM | 94K | SH | $2.80M 1.87% | 94K | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 555.26K | SH | $2.79M 1.87% | 555.26K | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 300.13K | SH | $2.40M 1.61% | 300.13K | 0.00 | 0.00 |
IKENA ONCOLOGY INCSOLE | COM | 551.01K | SH | $2.39M 1.60% | 551.01K | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 323.35K | SH | $2.09M 1.40% | 323.35K | 0.00 | 0.00 |
89BIO INCSOLE | COM | 33.80K | SH | $2.03M 1.36% | 33.80K | 0.00 | 0.00 |
Page 1 of 2